Prof Dr. Liu Yang | Bioinformatics | Best Researcher Award
Prof Dr. Liu Yang at Department of General Surgery, Jiangsu Cancer Hospital, China
👨‍🎓 Profile
👨‍⚕️ Current Position
Prof. Dr. Yang Liu is a Chief Physician and Associate Professor, serving as the Deputy Head of General Surgery at Jiangsu Cancer Hospital and the Head of Colorectal Surgery at Nanjing Medical University.
đź“ś Summary
Yang Liu is a prominent figure in colorectal surgery, also acting as a Master’s Supervisor and visiting overseas researcher at Thomas Jefferson University’s BluConner Hospital. His work has earned him multiple accolades in cancer research.
🎓 Education
Yang has completed his medical degree and advanced training in colorectal surgery, although specific institutions are not detailed here.
🏥 Professional Experience
With a focus on complex minimally invasive surgeries, he performs over 150 advanced procedures annually and actively participates in various national and provincial medical associations.
🔬 Research Interests
His research primarily explores ncRNA genomics in relation to colorectal cancer progression and metastasis, alongside developing innovative surgical techniques.
đź’ˇ Patents
Yang holds several patents, including:
- 2024: Combination of Scutellarein for colorectal cancer treatment.
- 2023: Multi-angle puncture holder.
- 2020: Circ-0000423 for colorectal cancer drug development.
- 2019: Surgical retractor for lower abdominal tumors.
🏆 Awards
He has received notable awards such as:
- 2021: 2nd Prize for New Medical Technology in Jiangsu for epigenetic fusion in colorectal cancer.
- 2019: 2nd Prize for his study on LINC00152 in colorectal cancer.
LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of STAT3
- Authors: Cao, Y., Zou, Z., Wu, X., Hu, J., Yang, L.
Journal: Gene
Year: 2024
Magnetic resonance imaging-based lymph node radiomics for predicting the metastasis of evaluable lymph nodes in rectal cancer
- Authors: Ye, Y.-X., Yang, L., Kang, Z., Du, M., Li, Z.-X.
Journal: World Journal of Gastrointestinal Oncology
Year: 2024
Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
- Authors: Wang, N., Cao, Y., Si, C., Bao, J., Yang, L.
Journal: Cancers
Year: 2022
FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer
- Authors: Li, D., Jiang, S., Zhou, X., Sun, Y., Yang, L.
Journal: Frontiers in Oncology
Year: 2022
Anal preservation on the psychology and quality of life of low rectal cancer
- Authors: Mei, F., Yang, X., Na, L., Yang, L.
Journal: Journal of Surgical Oncology
Year: 2022